What's new in diabetes? Inhaled insulin, novel drug class
Inhaled insulin and a new class of drugs for Type 2 diabetes are among the highlights of this year's ADA meeting
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Related Content
